Since AKT, also known as protein kinase B, is linked to and regulates many of the cancer hallmarks and the metastatic cascade in breast cancer [8–11], much effort was made to develop targeted therapy for AKT signaling in breast cancer [12–15]. This evidence concerns the gene AKT1 and breast carcinoma.